Dose Response of Ketorolac in Knee Arthroscopy
Completed · Not applicable
Conditions studied: Meniscectomy
In brief
Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.
Key facts
- Study ID
- NCT02181426
- Run by
- Medical University of South Carolina
- People needed
- 112
- Starts
- 2012-03-01
- Expected to finish
- 2016-12-15
- Last updated by the study team
- 2018-09-21
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ability to consent and desire to participate in study
- Outpatient knee arthroscopy with Dr. C. David Geier
- ASA physical status I-III
- 18-65 years old
- Over 50 kg (110 pounds)
- General anesthesia
You may not qualify if…
- Any contraindication to receiving a non-steroidal antiinflammatory medication (including but not limited to allergy to any non-steroidal antiinflammatory medications including aspirin; chronic renal insufficiency; history of gastric ulcers, gastritis, peptic ulcers or gastrointestinal bleeding; severe volume depletion; presence of cerebrovascular bleeding or high risk of bleeding)
- Allergy to propofol, fentanyl or hydromorphone.
- Any chronic painful conditions requiring opioid use for over the last 6 months
- Emergency surgery
- Altered mental status (not oriented to place, person or time)
- Pregnant or lactating patients
- Patient is taking non-steroidal antiinflammatory medications (including aspirin)1 at home and took that medication on day of surgery.
- Non-English speaking
- Patient refusal to study
- Patient refusal or not a candidate for general anesthesia with Laryngeal Mask Airway (LMA)
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.